It’s not the right time to quit: Editas Medicine Inc (EDIT) Stock
Citigroup raised the price target for the Editas Medicine Inc (NASDAQ:EDIT) stock from “a Neutral” to “a Buy”. The rating was released on October 24, 2023, according to finviz. The stock was upgraded by Stifel, who disclosed in a research note on September 29, 2023, from Hold to Buy and set the price objective to […]
Is Editas Medicine Inc (EDIT) Stock a good investment?
Citigroup raised the price target for the Editas Medicine Inc (NASDAQ:EDIT) stock from “a Neutral” to “a Buy”. The rating was released on October 24, 2023, according to finviz. The stock was upgraded by Stifel, who disclosed in a research note on September 29, 2023, from Hold to Buy and set the price objective to […]
Editas Medicine Inc (NASDAQ:EDIT) Stock is trading at a margin of -14.09% From 20-Day SMA
Citigroup raised the price target for the Editas Medicine Inc (NASDAQ:EDIT) stock from “a Neutral” to “a Buy”. The rating was released on October 24, 2023, according to finviz. The stock was upgraded by Stifel, who disclosed in a research note on September 29, 2023, from Hold to Buy and set the price objective to […]
Are Options A Good Investment Right Now? Editas Medicine Inc (EDIT) Stock
Citigroup raised the price target for the Editas Medicine Inc (NASDAQ:EDIT) stock from “a Neutral” to “a Buy”. The rating was released on October 24, 2023, according to finviz. The stock was upgraded by Stifel, who disclosed in a research note on September 29, 2023, from Hold to Buy and set the price objective to […]
The future looks bright for Editas Medicine Inc (EDIT) Stock
Citigroup raised the price target for the Editas Medicine Inc (NASDAQ:EDIT) stock from “a Neutral” to “a Buy”. The rating was released on October 24, 2023, according to finviz. The stock was upgraded by Stifel, who disclosed in a research note on September 29, 2023, from Hold to Buy and set the price objective to […]
Is it possible to sustain this rally? Editas Medicine Inc (EDIT) Stock
Citigroup raised the price target for the Editas Medicine Inc (NASDAQ:EDIT) stock from “a Neutral” to “a Buy”. The rating was released on October 24, 2023, according to finviz. The stock was upgraded by Stifel, who disclosed in a research note on September 29, 2023, from Hold to Buy and set the price objective to […]
Invest in Editas Medicine Inc (EDIT) Stock with the prospect of future returns
Citigroup raised the price target for the Editas Medicine Inc (NASDAQ:EDIT) stock from “a Neutral” to “a Buy”. The rating was released on October 24, 2023, according to finviz. The stock was upgraded by Stifel, who disclosed in a research note on September 29, 2023, from Hold to Buy and set the price objective to […]
